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Abstract
Introduction: The relationships between inhibin B, FSH and sperm count have never been fully elucidated. Our aim was to search for
associations between serum concentrations of inhibin B/FSH and the impairment of spermatogenesis.
Material and methods: In an observational study, we compared sperm count, serum levels of inhibin B and FSH in men with oligozo-
ospermia (n = 46) and in normozoospermic, fertile controls (n = 38).
Results: Concentration of FSH was 10.27 ± 11.24 IU/L in the oligozoospermic and 3.84 ± 2.76 IU/L in the normospermic group (p < 0.01).
Although the concentration of inhibin B was higher in the oligozoospermic group (424 ± 443 v. 297 ± 219 pg/mL), the difference was
statistically insignificant.
Conclusions: Our results suggest that there is a tendency toward increased serum inhibin B levels in subjects with altered sperm count
and increased serum FSH. (Pol J Endocrinol 2010; 61 (6): 695–698)
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Streszczenie
Wstęp: Związki między inhibiną B, FSH i obrazem nasienia nie zostały dotąd w pełni wyjaśnione. Celem pracy było poszukiwanie zależ-
ności między stężeniem inhibiny B i FSH a zaburzeniami spermatogenezy.
Materiał i metody: W badaniu o charakterze obserwacyjnym oceniano spermiogramy, osoczowe stężenie inhibny B i FSH u pacjentów
z oligozoospermią (n = 46) i w grupie mężczyzn normospermicznych, płodnych (n = 38).
Wyniki: Stężenie FSH wynosiło 10,27 ± 11,24 jm./l w grupie oligozoospermii i 3,84 ± 2,76 jm./l w grupie normospermii (p < 0,01). Nie
stwierdzono istotnej statystycznie różnicy pomiędzy stężeniem inhibiny B, które wyniosło w grupie normospermii i oligozoospermii
odpowiednio: 297 ± 219 i 424 ± 443 pg/ml (ns).
Wnioski: Uzyskane wyniki sugerują, że stężenie inhibiny B może być podwyższone u pacjentów z zaburzeniami spermatogenezy
i podwyższonym stężeniem FSH. (Endokrynol Pol 2010; 61 (6): 695–698)
Słowa kluczowe: inhibina B, FSH, spermiogram, komórki Sertoliego, idiopatyczna oligozoospermia
Introduction
Inhibin B belongs to the family of transforming growth
factors. It is produced by Sertoli cells and is thought to
be a marker of their function. Inhibin B influences in-
teractions between Sertoli cells and germ cells and
shows a negative feedback-loop with FSH [1–4]. Serum
concentrations of inhibin B and FSH closely correlate
with the functional status of Sertoli cells [5, 6].
Clinically, FSH is elevated in some but not all sub-
jects with severe disturbances of spermatogenesis.
On the other hand, a number of cases with minor
sperm count alterations present considerably in-
creased FSH.
In an observational study, we compared the serum
concentrations of inhibin B and FSH together with the
sperm count in men with idiopathic oligozoospermia
and also in normozoospermic, fertile controls.
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Material and methods
The protocol of the present study was approved by the
Bioethics Committee at Wroclaw Medical University.
Eighty-four men were enrolled for the investigation
(aged 26.75 ± 2.38). They were consecutive patients re-
ferred to the outpatient andrological clinic because of
marital infertility. They had no history of andrological
disturbances and did not present any pathology on an-
drological examination. Subjects with infections, chronic
diseases, abnormalities in the ultrasound imaging of the
testes or who had used hormonal therapies within the
previous six months were excluded.
In each subject, two spermiograms were acquired
with a time interval of 2–4 weeks (with 2–5 days sexual
abstinence before the examination). Sperm analysis was
performed manually according to the WHO criteria
(1999). Among the studied men, 46 had idiopathic oli-
gozoospermia (sperm concentration < 20 mln/mL) and
38 were considered as fertile controls (normal semen
analysis with fathered children).
Considering FSH plasma levels, the studied subjects
were divided into three groups: normozoospermia &
FSH < 11 IU/L, oligozoospermia & FSH < 11 IU/L (n = 30)
and oligozoospermia & FSH > 11 IU/L (n = 16).
We also evaluated the associations between FSH and
inhibin B in the three groups based upon sperm con-
centration: severe oligozoospermia (1–5 mln/mL), mild
oligozoospermia (5–20 mln/mL) and normozoospermia
( > 20 mln/mL).
Blood specimens were obtained between 8.00 and
9.00 a.m. from the ulnar vein. Serum was stored at
–20°C until use. FSH was determined by the IRMA meth-
od (Coat-A-Count, DPC, Los Angeles, CA, USA) and
inhibin B by the ELISA method (Diagnostic Systems
Laboratories, USA). The inter- and intra-assay variabil-
ity coefficients were respectively 5.7–5.0% and 3.8% for
FSH, and 7.6–6.2% and 3.5–5.6% for inhibin B. The nor-
mal range for FSH in men aged 20-50 is 2.0–11.0 IU/L.
Data was analysed using StatSoft’s STATISTICA
(data analysis software system), version 6.0. Pearson and
Spearman correlation coefficients were used for data
evaluation, and comparisons between groups were as-
sessed using the Mann-Whitney U test.
Results
Mean plasma FSH in men with normal sperm count
was 3.84 ± 2.76 IU/L and in men with oligozoospermia
10.27 ± 11.25 IU/L. The difference between two groups
was statistically significant (p < 0.01).
Mean plasma inhibin B was 297 ± 219 pg/mL in nor-
mozoospermic subjects and 424 ± 443 pg/mL in men
with oligozoospermia (Table I).
In a further analysis, we used sperm count to distin-
guish two subgroups among oligozoospermic subjects.
FSH in men with sperm concentration < 5 mln/mL was
13.90 ± 13.09 IU/L, while in subjects with sperm count
between 5 and 20 mln/mL it was 4.59 ± 2.61 UI/L (ns).
We did not observe any difference of FSH level among
subjects with normozoospermia, moderate and severe
oligozoospermia.
Distinct subgroups of men with oligozoospermia did
not differ as to mean concentration of inhibin B. In mod-
erately oligozoospermic men, it was 493 ± 552 pg/mL
while in severely oligozoospermic subjects, it was 377 ±
± 356 pg/mL. In normozoospermic volunteers the lev-
el of inhibin B was 297 ± 356 pg/mL (Table II).
We have not found any differences of inhibin B levels
among groups distinguished upon FSH concentration.
Table I. Serum concentrations of FSH and inhibin B in normospermic and oligozoospermic men (mean ± SD)
Tabela I. Osoczowe stężenia FSH i inhibiny B u mężczyzn normospermicznych i oligozoospermicznych (średnia arytmetyczna ±
± odchylenie standardowe)
Normospermia (n = 38) Oligozoospermia  (n = 46) p value*
FSH [IU/L] 3.84 ± 2.76 10.27 ± 11.24  < 0.01
Inhibin B [pg/mL] 297 ± 219 424 ± 443 ns
*Mann-Whitney U test; ns — non-significant
Table II. FSH and inhibin B concentrations in subjects with:
severe oligozoospermia (< 5 mln/mL), moderate oligozo-
ospermia (> 5–20 mln/mL) and normospermia (> 20 mln/mL).
Data presented as mean ± SD. Differences among groups were
statistically insignificant
Tabela II. Stężenia FSH i inhibiny B u mężczyzn z: ciężką
oligozoospermią (< 5 mln/ml), umiarkowaną oligozoospermią
(> 5–20 mln/ml) i normospermią (> 20 mln/ml). Dane
przedstawione jako średnia arytmetyczna ± odchylenie
standardowe. Różnice pomiędzy grupami nie osiągnęły
istotności statystycznej
Groups FSH Inhibin B
[IU/L]  [pg/mL]
Severe oligozoospermia (n = 25) 13.90 ± 13.06 377 ± 356
Moderate oligozoospermia (n = 21) 4.59 ± 2.61 493 ± 552
Normospermia (n = 38) 3.84 ± 2.76 297 ± 219
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Though oligozoospermic men with FSH < 11 IU/L had
markedly higher inhibin B level than oligozoospermic
men with FSH ≥ 11 IU/L, the observed difference was
statistically insignificant (Table III).
Discussion
In spite of our growing knowledge as to the function of
male gonads [7–9], clinical assessment of specific cases
often turns out to be difficult. Routine seminal and hor-
monal evaluations give only an approximate picture
of the pathologies underlying the disturbances of sper-
matogenesis. Thus in many cases alterations of sper-
matogenesis are classified as idiopathic. Evaluation of
inhibin B level has raised some interest because of its
negative correlation with FSH and due to its influence
on interactions between Sertoli and germ cells [10].
Although the clinical value of inhibin has been ques-
tioned [11, 12], most authors agree as to the presence of
a close relationship between concentrations of inhibin
B in serum and the status of spermatogenesis [13–17].
De Kretser et al. evaluated serum concentrations of
inhibin and gonadothropins in 39 normal men and
127 infertile subjects. They found no correlation be-
tween inhibin and the level of testicular damage or FSH
concentration [11]. Kolb et al. observed that concentra-
tions of inhibin B in men with testicular or primary germ
cell failure is lower than in fertile controls. It was also
decreased in patients with idiopathic hypogonadotro-
pic hypogonadism. In one case of Kallmann syndrome,
inhibin B was undetectable [6].
In another study, Foresta et al. showed that men with
Sertoli cell only syndrome (SCOS), severe hyposper-
matogenesis and spermatogonial/spermatocytic arrest
had lower levels of inhibin B than men with obstruc-
tive azoospermia and spermatic arrest or healthy con-
trols. Nevertheless, they pointed to the fact that a con-
siderable subgroup of subjects with SCOS had normal
levels of inhibin B [12]. Yet other authors showed that
infertile men had lower concentrations of inhibin B and
higher concentrations of FSH than healthy men from
the general population [18].
Our study found no statistically significant differ-
ences of inhibin B between men with normospermia
and men with testicular impairment. Inhibin B did not
differ among groups distinguished upon FSH level, ei-
ther. However, we noticed a tendency toward a higher
concentration of inhibin B in men with altered sper-
matogenesis. This was not evident as concentration of
inhibin B was higher in men with oligozoospermia and
normal FSH, and lower in men with oligozoospermia
and increased FSH.
Our results agree with suggestions that not only
Sertoli cells, but also germ cells, affect the level of inhib-
in B. It is worth mentioning that b subunits of inhibin B
are found in germ cells (pachytene spermatocytes and
early spermatides), while both a and b subunits are
present in Sertoli cells [11, 19, 20]. These observations
lead to a hypothesis that inhibin B consists of two sub-
units: a subunit deriving from Sertoli cells, and b from
germ cells. Thus a lack of germ cells could result in the
production of biologically inactive a chains, something
in fact that has been observed in some men with
azoospermia (SCOS, radiation-induced testicular dam-
age) with accompanying increased levels of FSH.
Increased inhibin B and normal FSH should confirm
the proper function of the loop inhibin B-FSH and an
efficient secretory function of Sertoli cells. In our study,
it was true for the group with sperm concentration be-
tween 5–20 mln/mL. Increased concentration of inhib-
in B in these subjects went along with mild, idiopathic
alterations of spermatogenesis.
Subjects with decreased inhibin B and increased FSH
may present a damage at first steps of spermatogene-
sis. This rationale is consistent with the results present-
ed by Foresta et al. [21]. They compared a group of men
with DAZ gene deletion to three groups of men with
mild, moderate and severe alterations of spermatogen-
esis. Patients with DAZ gene deletion had increased FSH
and normal inhibin B. Such hormonal constellation sug-
gested normal function of Sertoli cells and appropriate
interactions between Sertoli and germ cells. Men with
severe testiculopathies had increased FSH, decreased
inhibin B and did not respond to FSH treatment. This
could be explained by the damage to both Sertoli and
germ cells. The same authors made a hypothesis that
Sertoli cells could be at their maximal functional capa-
bility in men with idiopathic disturbances (who had
increased FSH and normal inhibin B) [21, 22].
Leifke et al. presented data on significantly higher
inhibin B plasma levels in men with focal SCOS com-
pared to complete SCOS. They suggested that secretion
Table III. Inhibin B serum concentration in subgroups
distinguished upon combined sperm concentration and FSH
level. Data presented as mean ± SD. Differences among groups
were statistically insignificant
Tabela III. Osoczowe stężenie inhibiny B w podgrupach
wyodrębnionych na podstawie liczby plemników i stężenia
FSH. Dane przedstawione jako średnia arytmetyczna ±
± odchylenie standardowe. Różnice pomiędzy grupami nie
osiągnęły istotności statystycznej
Groups Inhibin B [pg/mL]
Normospermia & FSH < 11 IU/L (n = 38) 297±219
Oligozoospermia & FSH < 11 IU/L (n = 30) 453±492
Oligozoospermia & FSH ≥ 11 IU/L (n = 16) 352±296
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of inhibin B may depend not only on Sertoli cells, but
also on the spermatogenic activity within seminifer-
ous tubules [23]. Similarly to patients with SCOS, sub-
jects with bilateral atrophy of testes had elevated
levels of FSH.
In line with with previous reports, our results point
to a possible association between alterations of sper-
matogenesis and serum levels of inhibin B and FSH.
However, these relations are not evident when only
routine analyses (such as FSH and sperm count) are
considered.
We have not found statistically significant differenc-
es of inhibin B serum levels between normozoosper-
mic and oligozoospermic men.
Conclusions
Our results suggest that serum inhibin B may be ele-
vated in subjects with altered sperm count and increased
serum FSH.
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